Tuberculosis drug discovery and emerging targets

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2014-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/nyas.12459PMID 24920100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA.

  2014cited by this paper
• Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA.

  2014cited by this paper
• A new unifying theory of the pathogenesis of tuberculosis.

  2014cited by this paper
• Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing

  2013cited by this paper
• Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3

  2013cited by this paper
• Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis

  2013cited by this paper
• Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis

  2013cited by this paper
• Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis

  2013cited by this paper
• Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.

  2013cited by this paper
• A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

  2013cited by this paper
• Perturbation of Cytochrome c Maturation Reveals Adaptability of the Respiratory Chain in Mycobacterium tuberculosis

  2013cited by this paper
• Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?

  2013cited by this paper
• LC-MS based assay to measure intracellular compound levels in Mycobacterium smegmatis: linking compound levels to cellular potency.

  2013cited by this paper
• Aberrant Free Radical Biology Is a Unifying Theme in the Etiology and Pathogenesis of Major Human Diseases

  2013cited by this paper
• The Mycobacterium tuberculosis Secreted Protein Rv0203 Transfers Heme to Membrane Proteins MmpL3 and MmpL11*

  2013cited by this paper
• Activated ClpP kills persisters and eradicates a chronic biofilm infection

  2013cited by this paper
• The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylation.

  2013cited by this paper
• Whole Cell Screen for Inhibitors of pH Homeostasis in Mycobacterium tuberculosis

  2013cited by this paper
• Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis

  2013cited by this paper
• A High-Throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-Cyanopyrrole-2-Carboxylic Acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis

  2013cited by this paper
• Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents.

  2013cited by this paper
• Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis.

  2013cited by this paper
• Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery

  2013cited by this paper
• Disruption of mycobactin biosynthesis leads to attenuation of Mycobacterium tuberculosis for growth and virulence.

  2013cited by this paper
• Inhibition of the First Step in Synthesis of the Mycobacterial Cell Wall Core, Catalyzed by the GlcNAc-1-phosphate Transferase WecA, by the Novel Caprazamycin Derivative CPZEN-45*

  2013cited by this paper
• Developing new antibacterials through natural product research

  2013cited by this paper
• Antitubercular pharmacodynamics of phenothiazines.

  2013cited by this paper
• Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and Nanomolar Activity Against Mycobacterium tuberculosis.

  2013cited by this paper
• Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species

  2013cited by this paper
• Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32

  2013cited by this paper
• Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

  2013cited by this paper
• FadD3 is an acyl‐CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria

  2013cited by this paper
• Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.

  2013cited by this paper
• Glucose Phosphorylation Is Required for Mycobacterium tuberculosis Persistence in Mice

  2013cited by this paper
• Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.

  2013cited by this paper
• High lipophilicity and high daily dose of oral medications are associated with significant risk for drug‐induced liver injury

  2013cited by this paper
• Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.

  2013cited by this paper
• Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.

  2013cited by this paper
• Contributions of molecular properties to drug promiscuity.

  2013cited by this paper
• Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis

  2013cited by this paper
• Discovery of a Siderophore Export System Essential for Virulence of Mycobacterium tuberculosis

  2013cited by this paper
• A single-cell perspective on non-growing but metabolically active (NGMA) bacteria.

  2013cited by this paper
• Structure-guided discovery of phenyl-diketo acids as potent inhibitors of M. tuberculosis malate synthase.

  2012cited by this paper
• A Ferritin Mutant of Mycobacterium tuberculosis Is Highly Susceptible to Killing by Antibiotics and Is Unable To Establish a Chronic Infection in Mice

  2012cited by this paper
• Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals

  2012cited by this paper
• Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB

  2012cited by this paper
• The Role of Transport Mechanisms in Mycobacterium Tuberculosis Drug Resistance and Tolerance

  2012cited by this paper
• SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis

  2012cited by this paper
• Stable Analogues of OSB‐AMP: Potent Inhibitors of MenE, the o‐Succinylbenzoate‐CoA Synthetase from Bacterial Menaquinone Biosynthesis

  2012cited by this paper
• University of Birmingham Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB

  2012cited by this paper
• Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.

  2012cited by this paper
• University of Birmingham Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors

  2012cited by this paper
• Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.

  2012cited by this paper
• A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis

  2012cited by this paper
• A Common Mechanism of Inhibition of the Mycobacterium tuberculosis Mycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone*

  2012cited by this paper
• Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening.

  2012cited by this paper
• Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.

  2012cited by this paper
• Natural products as leads for tuberculosis drug development.

  2012cited by this paper
• Advances in mycobacterial isocitrate lyase targeting and inhibitors.

  2012cited by this paper
• Iron metabolism and the innate immune response to infection.

  2012cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012cited by this paper
• Antimycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds.

  2012cited by this paper
• Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening.

  2012cited by this paper
• Towards a new tuberculosis drug: pyridomycin – nature's isoniazid

  2012cited by this paper
• Targeting InhA, the FASII enoyl-ACP reductase: SAR studies on novel inhibitor scaffolds.

  2012cited by this paper
• MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria

  2012cited by this paper
• A novel F420-dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents

  2012cited by this paper
• Application of SBDD to the discovery of new antibacterial drugs.

  2012cited by this paper
• Recent advances in antitubercular natural products.

  2012cited by this paper
• Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosis

  2012cited by this paper
• Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target

  2011cited by this paper
• INHIBITION OF MYCOLIC ACID TRANSPORT ACROSS THE MYCOBACTERIUM TUBERCULOSIS PLASMA MEMBRANE

  2011cited by this paper
• The structure-activity relationship of urea derivatives as anti-tuberculosis agents.

  2011cited by this paper
• Screening strategies for discovery of antibacterial natural products

  2011cited by this paper
• 13C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria which Requires Isocitrate Lyase and Carbon Dioxide Fixation

  2011cited by this paper
• Depletion of antibiotic targets has widely varying effects on growth

  2011cited by this paper
• Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis

  2011cited by this paper
• Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions

  2011cited by this paper
• High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism

  2011cited by this paper
• Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression

  2011cited by this paper
• Activity of 3-Ketosteroid 9α-Hydroxylase (KshAB) Indicates Cholesterol Side Chain and Ring Degradation Occur Simultaneously in Mycobacterium tuberculosis*

  2011cited by this paper
• A Screen to Identify Small Molecule Inhibitors of Protein–Protein Interactions in Mycobacteria

  2011cited by this paper
• Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes.

  2011cited by this paper
• Action-mechanism of trichoderin A, an anti-dormant mycobacterial aminolipopeptide from marine sponge-derived Trichoderma sp.

  2011cited by this paper
• Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier.

  2011cited by this paper
• Pathway Profiling in Mycobacterium tuberculosis

  2011cited by this paper
• Iron Storage Proteins Are Essential for the Survival and Pathogenesis of Mycobacterium tuberculosis in THP-1 Macrophages and the Guinea Pig Model of Infection

  2011cited by this paper
• Discovery and characterization of a unique mycobacterial heme acquisition system

  2011cited by this paper
• CoA Adducts of 4-Oxo-4-Phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis Pathway.

  2011cited by this paper
• Antituberculosis cycloartane triterpenoids from Radermachera boniana.

  2011cited by this paper
• Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.

  2011cited by this paper
• MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212

  2011cited by this paper
• Cholesterol Is Not an Essential Source of Nutrition for Mycobacterium tuberculosis during Infection

  2011cited by this paper
• Pathway Profiling in Mycobacterium tuberculosis : Elucidation of a Cholesterol-Derived Catabolite and the Enzymes that Catalyze its Metabolism

  2011cited by this paper
• A Flavin-dependent Monooxygenase from Mycobacterium tuberculosis Involved in Cholesterol Catabolism*

  2010cited by this paper
• Characterization of a Clp Protease Gene Regulator and the Reaeration Response in Mycobacterium tuberculosis

  2010cited by this paper
• Crystallization and preliminary X-ray crystallographic analysis of a Mycobacterium tuberculosis ferritin homolog, BfrB.

  2010cited by this paper
• Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism

  2010cited by this paper
• Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase

  2010cited by this paper
• Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection

  2010cited by this paper

• Advancements in Tuberculosis Diagnostics: An Update.

  2025cites this paper
• Synthesis of 6-dialkylaminopyrimidine carboxamide analogues and their anti-tubercular properties

  2024cites this paper
• Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnostics

  2023cites this paper
• Discovery of benzo[c]phenanthridine derivatives with potent activity against multidrug-resistant Mycobacterium tuberculosis

  2022cites this paper
• Synthesis of Novel Derivatives of 5,6,7,8-Tetrahydroquinazolines Using α-Aminoamidines and In Silico Screening of Their Biological Activity

  2022cites this paper
• A review of the medicinal plants with immune-boosting potential

  2022cites this paper
• Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular Mycobacterium tuberculosis

  2022cites this paper
• Challenges in Drug Discovery against Tuberculosis

  2021cites this paper
• Pharmacophore mapping of the crucial mediators of dual inhibitor activity of PanK and PyrG in tuberculosis disease

  2021cites this paper
• Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.

  2020cites this paper
• Investigation of the anti-TB potential of selected alkaloid constituents using molecular docking approach

  2020cites this paper
• Hybrid Pharmacophore Approach as a Novel Strategy to identify Anti-Mycobacterial Chemotypes: Investigation with DapB Enzyme

  2020cites this paper
• Probing the dual inhibitory mechanisms of novel thiophenecarboxamide derivatives against Mycobacterium tuberculosis PyrG and PanK: an insight from biomolecular modeling study

  2020cites this paper
• Diversité des plantes utilisées dans la médecine traditionnelle contre les principaux symptômes de la COVID-19 en Afrique subsaharienne: revue de littérature

  2020influential citation
• NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G

  2019cites this paper
• Molecular Dynamics Simulations in Drug Discovery

  2019cites this paper
• Dual targeting approach for Mycobacterium tuberculosis drug discovery: insights from DFT calculations and molecular dynamics simulations

  2019cites this paper
• Predictive Binding Affinity of Plant-Derived Natural Products Towards the Protein Kinase G Enzyme of Mycobacterium tuberculosis (MtPknG)

  2019cites this paper
• Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.

  2019cites this paper
• TREATMENT OF TUBERCULOSIS BY NATURAL DRUGS : A REVIEW

  2019cites this paper
• CitE Enzymes Are Essential for Mycobacterium tuberculosis to Establish Infection in Macrophages and Guinea Pigs

  2018cites this paper
• Recent advances for identification of new scaffolds and drug targets for Mycobacterium tuberculosis

  2018cites this paper
• Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.

  2018cites this paper
• Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach

  2018cites this paper
• Antimycobacterial Activity of Cinnamaldehyde in a Mycobacterium tuberculosis(H37Ra) Model

  2018cites this paper
• Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti-tuberculosis activity

  2018cites this paper
• Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis

  2018cites this paper
• African Medicinal Plants that Can Control or Cure Tuberculosis

  2018cites this paper
• Anti-tuberculosis therapy: Urgency for new drugs and integrative approach

  2018influential citation
• Deconvolution of Mycobacterium tuberculosis drug targets using high throughput screening approaches

  2018cites this paper
• African Medicinal Plants that Can Control or Cure Tuberculosis

  2018cites this paper
• Current challenges in drug discovery for tuberculosis

  2017cites this paper
• Novel Targets in Drug Discovery

  2017cites this paper
• Strategies for Tackling Drug Resistance in Tuberculosis

  2017cites this paper
• Drug development against tuberculosis: Impact of alkaloids.

  2017cites this paper
• Drug Design: Principles and Applications

  2017cites this paper
• Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds †

  2017cites this paper
• Partial Depletion of Pth Increases Susceptibility to Macrolide Drug Treatment in M. Tuberculosis

  2016cites this paper
• Mycobacterium bovis: realities and challenges for the veterinary biopharmaceutical industry

  2016cites this paper
• A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action

  2016cites this paper
• SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc 1 inhibitors

  2016cites this paper
• Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.

  2016cites this paper
• Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery

  2016cites this paper
• Current perspectives in drug discovery against tuberculosis from natural products.

  2015cites this paper
• Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets.

  2015cites this paper
• Mycobacterial Dihydrofolate Reductase Inhibitors Identified Using Chemogenomic Methods and In Vitro Validation

  2015cites this paper
• FACULTAD DE FARMACIA UNIVERSIDAD COMPLUTENSE

  2015cites this paper
• Targeting microbial virulence factors : potential alternative to evade the antimicrobial resistance threats

  2015cites this paper
• Thioridazine for treatment of tuberculosis: promises and pitfalls.

  2014cites this paper
• Introduction to Antimicrobial Therapeutics Reviews: Infectious Diseases of Current and Emerging Concern

  2014cites this paper